SNOA Earnings

Quarterly EPS
$-0.59
Q2 2025
$-0.63
Q3 2025
$-0.48
Q4 2025
$-0.76
Q1 2026
$-0.32
Q2 2026
$-0.48
Q3 2026
$-0.33
Q4 2026
$-0.09
Q1 2027
Latest Revenue6.4M
Latest Net Income-330000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2027-$0.096.4M-330000+59.6%+88.2%
Q4 2026-$0.335.6M-581000+48.1%+31.2%
Q3 2026-$0.484.3M-819000+22.0%+23.8%
Q2 2026-$0.325.6M-534000+56.6%+45.8%
Q1 2026-$0.764.0M-1241000+18.4%+43.3%
Q4 2025-$0.483.8M-776000+9.2%+31.4%
Q3 2025-$0.633.6M-928000+13.6%+60.4%
Q2 2025-$0.593.6M-610000+31.1%+89.7%
Q1 2025-$1.343.4M-1143000——
Q4 2024-$0.703.4M-1067000——
Q3 2024-$1.593.1M-866000——
Q2 2024-$5.752.7M-1484000——
Sonoma Pharmaceuticals (SNOA) — Earnings